What Does the FDA Say About Transvaginal Mesh Products?
The Food and Drug Administration (FDA), the federal agency responsible for protecting Americans from harmful medical devices, has issued repeated warnings about the risks of transvaginal mesh devices. In particular, the FDA has warned that serious complications associated with surgical mesh repairs are not rare and that the evidence is unclear as to whether a transvaginal pelvic organ prolapse (POP) repair is more effective than more traditional, non-invasive, non-mesh repair technology.
Is the FDA’s warning news to you? It’s a surprise to a lot of Americans and, more importantly, a lot of transvaginal mesh patients. Unfortunately, in some instances transvaginal mesh manufacturers have been slow to warn doctors and their patients about the risks of this potentially dangerous medical device.
Have you experienced pain or discomfort in the weeks or months following your POP or SUI surgery? These symptoms may be indicative of a larger problem with your transvaginal mesh implant. To find out whether your rights have been violated, contact the experts at Fears Nachawati. Our attorneys can protect your interests. For your free consultation, call us at 1.866.545.8364 or email email@example.com.